Working… Menu
Trial record 1 of 1 for:    NCT02310243
Previous Study | Return to List | Next Study

Study of Palbociclib in MLL-rearranged Acute Leukemias

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02310243
Recruitment Status : Recruiting
First Posted : December 8, 2014
Last Update Posted : April 16, 2019
National Center for Tumor Diseases, Heidelberg
Information provided by (Responsible Party):
Peter Paschka, University of Ulm

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2019
Estimated Study Completion Date : July 2019